According to AgFunderNews, company cofounder and CEO Dr. Gregor Tegl announced the news on LinkedIn, and also affirmed his belief in the potential of the technology. “Every failure teaches us something new, and the lessons we’ve learned about scaling our technology, engaging with stakeholders, and navigating regulatory landscapes will stay with me as I move forward.”
The company was founded in 2021 and raised over $13 million. It operated a pilot plant in Vienna producing 20 amino acids from single-celled microbes fed CO2 and hydrogen.